Savills, for its client Henkel Ltd, has brought to the market a fully functional and licensed chemical mixing factory at the Belvedere Industrial Estate in Kent, UK, for a guide price of L3.5 million ($5.2 million).
The freehold complex, owned and formerly occupied by Henkel, comprises a factory of around 54,000 sq ft (5,016 sq m) on a 5.5 acres (2.2 hectares) site. There are three units, which include warehousing, production and maintenance facilities, as well as a self-contained office building totalling 6,000 sq ft (557 sq m). The production areas are all fully-fitted with holding tanks and a computerized mixing system, which the purchaser can retain. Henkel will begin decommissioning in January 2009.
Graham Brown, director of Savills, comments: "This is a very unusual opportunity to acquire a fully-licensed and functioning factory the likes of which rarely come to the market. With an excellent location in an established industrial area close to Junction 1A of the M25, we anticipate good interest in the factory."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze